Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 121 - 140 of 495 trials
Titlesort icon Investigator Disease(s)
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of BYL719 plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Cancer
[Protocol 14-021]
Fury, Matthew
  • Head & Neck Cancer
A Phase I/II Study of Cabozantinib (XL184) in Patients with Recurrent or Persistent Myeloma
Relapsed/Refractory
[Protocol 12-240]
Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Phase I/II Study of Crizotinib and Ganetespib (STA-9090) in ALK-Positive Lung Cancers
[Protocol 12-015]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer
[Protocol 10-165]
Dalbagni, Guido
  • Bladder Cancer
A Phase I/II Study of Gemcitabine, Cisplatin, and MEK162 as Initial Treatment for Advanced Bile Duct or Gallbladder Cancer
[Protocol 13-004]
Lowery, Maeve
  • Hepatobiliary
  • Upper Gastrointestinal
A Phase I/II Study of GSK525762 in Patients with Persistent Hematologic Cancers
[Protocol 13-202]
Stein, Eytan
  • Hematology
    • Multiple Myeloma
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of IMO-8400 in Patients with Persistent or Recurrent Waldenstrom's Macroglobulinemia
[Protocol 14-078]
Palomba, M. Lia
  • Hematology
    • Hematologic Malignancies
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123]
Pentsova, Elena
  • Breast Cancer
A Phase I/II Study of Ipilimumab Given with Abiraterone and Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
[Protocol 12-120]
Danila, Daniel
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I/II Study of Low-Dose Cytarabine and Lintuzumab-Ac-225 in Older Patients with Previously Untreated Acute Myeloid Leukemia
Newly Diagnosed
[Protocol 09-053]
Park, Jae
  • Leukemia
A Phase I/II Study of M402 in Combination with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-078]
O'Reilly, Eileen
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I/II Study of Nivolumab Alone and with Ipilimumab in Patients with Advanced or Metastatic Solid Tumors
Relapsed/Refractory
[Protocol 13-187]
Callahan, Margaret
  • Breast Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I/II Study of Oral Azacitidine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes after Receiving a Stem Cell Transplant from a Donor
[Protocol 13-160]
Papadopoulos, Esperanza
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of Paclitaxel, Cisplatin, and ABT-888 (Velaparib) to Treat Advanced, Persistent, or Recurrent Cervical Cancer
[Protocol 11-131]
Leitao, Mario
  • Cervical Cancer
A Phase I/II Study of Pazopanib plus MK-3475 (Pembrolizumab) in Patients with Previously Untreated, Inoperable Advanced Kidney Cancer
[Protocol 14-074]
Voss, Martin
  • Kidney Cancer
A Phase I/II Study of PLX3397 to Treat Patients with Acute Myeloid Leukemia that Has Returned or Persisted Despite Therapy
Relapsed/Refractory
[Protocol 13-204]
Stein, Eytan
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of Pomalidomide and Dexamethasone with and without Ixazomib in Patients with Recurrent Multiple Myeloma
[Protocol 14-055]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase I/II Study of Ruxolitinib plus Erlotinib in Patients with Erlotinib-Resistant Lung Adenocarcinoma
[Protocol 14-043]
Yu, Helena
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of SC16LD6.5 in Patients with Recurrent Small Cell Lung Cancer
[Protocol 13-184]
Pietanza, M. Catherine
  • Lung Cancer, Small Cell